Serological and Molecular Detection of Coxiella Burnetii in Clinical Samples from Veterinarians and Cattle Farm Workers from Gabrovo Region, Bulgaria
AbstractCoxiella burnetii, which causes Q fever, is a highly infectious agent that is widespread around the world. During the last decades, the number of cases reported in Bulgaria varied from year to year. The present study aimed to determine the frequency of C. burnetii infection using ELISA and conventional PCR among freelance veterinarians and cattle farm workers in Gabrovo province, Bulgaria. In the period April 2020 to June, 2021 a total of 154 blood samples of target group was tested in the National Reference Laboratory of Cell cultures, rickettsia and oncogenic viruses (NRL CCROV) at NCIPD - Sofia. Diagnosis of C. burnetii was performed by indirect enzyme-linked immunosorbent assay ELISA (anti-Coxiella burnetii ph. II IgG/IgM) and by end-point PCR technique (to detect the sodB gene region of C. burnetii). By indirect ELISA assay of the tested 154 clinical samples, anti-C. burnetii positive ph. II IgM antibodies were registered in 37% of samples. A relatively high percentage are affected in the active age between 50-60 years old. Anti-C. burnetii positive ph. II IgG antibodies were proven at 50% of tested samples. A positive PCR signal for C. burnetii DNA was obtained at 37/154 (20% of samples) and follows the above reported trend of acute infection of active age patients. Around 10% of tested samples were positive for three C. burnetii laboratory markers. We conclude that Q fever is endemic in Bulgaria. More research is necessary in different Bulgarian regions to set the human risk groups, to diagnose acute and chronic Q fever and to determine the economic impact of Q fever in the cattle industry. In the NRL CCROV was developed diagnostic scheme including complex methods to improve early laboratory diagnosis of C. burnetii, allowing taking proper treatment of suspected with Q fever patients.
. Jones K, Patel N, Levy M, et al. (2008). “Global trends in emerging infectious diseases”. Nature. 451:990-94. Available: https://doi.org/10.1038/nature06536
. Karesh W, Dobson A, Lloyd-Smith J, et al. (2012). “Ecology of zoonoses: natural and unnatural histories”. Lancet. 380:1936–45. Available: https://doi.org/10.1016/S0140-6736(12)61678-X.
. Mishra J., Mishra P. & Arora N. (2021). “Linkages between environmental issues and zoonotic diseases: with reference to COVID-19 pandemic”. Environmental Sustainability. Available: https://doi.org/10.1007/s42398-021-00165-x
. Campbell-Lendrum D, Manga L, Bagayoko M, Sommerfeld J. (2015). “Climate change and vector-borne diseases: what are the implications for public health research and policy?”. Philos Trans R Soc Lond B Biol Sci. 370(1665):20130552. Available: https://doi.org/10.1098/rstb.2013.0552
. Brook C, Dobson A. (2015). “Bats as ‘special’ reservoirs for emerging zoonotic pathogens”. Trends in Microbiology. 23: 172– 180. Available: https://doi.org/10.1016/j.tim.2014.12.004
. Porter S, Czaplicki G, Mainil J, Guattéo R, Saegerman C. (2011). “Q Fever: current state of knowledge and perspectives of research of a neglected zoonosis”. Int J Microbiol. 248418. Available: https://doi.org/10.1155/2011/248418
. Eldin C, Mélenotte C, Mediannikov O, Ghigo E, Million M, Edouard S, et al. (2017) “From Q Fever to Coxiella burnetii Infection: a Paradigm Change”. Clin Microbiol Rev. 30(1):115–90. pmid:27856520. Available: https://doi.org/10.1128/CMR.00045-16
. Kagawa F, Wehner J., Mohindra. (2003) “Q fever as a biological weapon”. Eur PMC, 18, 183 - 195.
. Woldehiwet Z. (2004). “Q fever (coxiellosis): epidemiology and pathogenesis”. Res Vet Sci. 77:93–100. pmid:15196898. Available: https://doi.org/10.1016/j.rvsc.2003.09.001
. Tissot-Dupont H, Raoult D. (2008, Sep) Q fever. Infect Dis Clin North Am. 22(3):505-14, ix. Available: https://doi.org/10.1016/j.idc.2008.03.002
. Angelakis E, Raoult D. (2010). “Q fever”. Vet Microbiol. 140: 297–309. Available: https://doi.org/10.1016/j.vetmic.2009.07.016
. Arricau-Bouvery N, Rodolakis A. (2005). “Is Q Fever an emerging or re-emerging zoonosis?”. Veterinary Research, BioMed Central. 36 (3), pp.327-349. Available: https://hal.archives-ouvertes.fr/hal-00902979
. Honarmand H. (2012). "Q Fever: An Old but Still a Poorly Understood Disease", Interdisciplinary Perspectives on Infectious Diseases, vol. 2012, Article ID 131932, 8 pages. Available: https://doi.org/10.1155/2012/131932
. Healy B, Llewelyn M, Westmoreland D, Lloyd G, Brown N. (2006). “The value of follow-up after acute Q fever infection,” Journal of Infection, vol. 52, no. 4, pp. e109–e112.
. Million M, Walter G, Thuny F, Habib G, Raoult D. (2013, Sep). “Evolution from acute Q fever to endocarditis is associated with underlying valvulopathy and age and can be prevented by prolonged antibiotic treatment”. Clin Infect Dis. 57(6):836-44. Available: https://doi.org/10.1093/cid/cit419
. Wegdam-Blans MC, Vainas T, van Sambeek MR, et al. (2011). “Vascular complications of Q-fever infections”. Eur J Vasc Endovasc Surg. 42(3):384–392. Available: https://doi.org/10.1016/j.ejvs.2011.04.013
. Fournier P, Raoult D. (2003). “Comparison of PCR and serology assays for early diagnosis of acute Q fever|. J. Clin. Microbiol. 41:5094–5098. Available: https://doi.org/10.1128/JCM.41.11.5094-5098.2003
. Schneeberger P, et al. (2010). “Real-time PCR with serum samples is indispensable for early diagnosis of acute Q fever”. Clin. Vaccine Immunol. 17:286–290. Available: https://doi.org/10.1128/CVI.00454-09
. Wegdam-Blans M, Wielders C, Meekelenkamp J, et al. (2012). “Evaluation of commonly used serological tests for the detection of Coxiella burnetii antibodies in well-defined acute and followup sera”. Clin Vaccine Immunol. 19:1110–1115.
. Dupuis G, Péter O, Peacock M, Burgdorfer W, Haller E. (1985). “Immunoglobulin responses in acute Q fever”. J. Clin. Microbiol. 22:484–487. Available: https://doi.org/10.1128/jcm.22.4.484-487.1985
. Aitken ID, Bögel K, Cračea E, et al. (1987). “Q fever in Europe: current aspects of aetiology, epidemiology, human infection, diagnosis and therapy”. Infection. 15(5):323–327. Available: https://doi:10.1007/BF01647731
. Frankel D, Richet H, Renvoisé A, Raoult D. (2011). “Q fever in France, 1985-2009”. Emerg Infect Dis. 17(3):350-356. Available: https://doi.org/10.3201/eid1703.100882
. Amitai Z, Bromberg M, Bernstein M, Raveh D, Keysary A, David D, et al. (2010). “A large Q fever outbreak in an urban school in central Israel”. Clin Infect Dis. 50:1433–8. Available: https://doi.org/10.1086/652442
. Enserink M. (2010). “Infectious diseases. Questions abound in Q-fever explosion in the Netherlands”. Science. 327:266–7. Available: https://doi.org/10.1126/science.327.5963.266-a
. Hellenbrand W, Breuer T, Petersen L. (2001). “Changing epidemiology of Q fever in Germany, 1947–1999”. Emerg Infect Dis. 7:789–96. Available: https://doi.org/10.3201/eid0705.010504
. Wallensten A, Moore P, Webster H, Johnson C, van der Burgt G, Pritchard G, et al. (2010). “Q fever outbreak in Cheltenham, United Kingdom, in 2007 and the use of dispersion modelling to investigate the possibility of airborne spread”. Euro Surveill. 15:19521. Available: https://doi.org/10.2807/ese.15.12.19521-en
. Anderson A. et al. (2013). “Diagnosis and management of Q fever–United States, 2013: Recommendations from CDC and the Q Fever Working Group”. MMWR Recomm. Rep. 62, 1–30. Available: https://www.cdc.gov/mmwr/preview/mmwrhtml/rr6203a1.htm
. Mitov A, Shindarov L, Serbezov V. (1959). “Q fever in Bulgaria”. Mod Med. 1-2:39-46.
. Serbezov V, Kazár J, Novkirishki V, Gatcheva N, Kovácová E, Voynova V. (1999). “Q fever in Bulgaria and Slovakia”. Emerg Infect Dis. 5(3):388-94. Available: https://doi.org/10.3201/eid0503.990309
. Kamenov G, Tiholova M. (2004). “Q fever outbreak in Botevgrad, Bulgaria: May-June 2004”. Euro Surveill. 8(35):2535. Available: https://doi.org/10.2807/esw.08.35.02535-en
. Genova-Kalou P, Vladimirova N, Stoitsova S, Krumova S, Kurchatova A, Kantardjiev T. (2019). “Q fever in Bulgaria: Laboratory and epidemiological findings on human cases and outbreaks, 2011 to 2017”. Euro Surveill. 24(37):1900119. Available: https://doi.org/10.2807/1560-7917.ES.2019.24.37.1900119
. Stein A, Raoult D. (1992). “Detection of Coxiella burnetti by DNA amplification using polymerase chain reaction”. J Clin Microbiol. 30(9):2462-6. Available: https://doi.org/10.1128/jcm.30.9.2462-2466.1992
. Mathews K, Toribio J, Norris J, Phalen D, Wood N, Graves S, Sheehy P, Bosward K. (2020, Nov). Coxiella burnetii seroprevalence and Q fever in Australian wildlife rehabilitators. One Health; 12:100197. Available: https://doi: 10.1016/j.onehlt.2020.100197.
. Miller H, Kersh G. (2020, Dec). Analysis of recombinant proteins for Q fever diagnostics. Sci Rep. 1; 10(1):20934. Available: https://doi: 10.1038/s41598-020-77343-0.
Copyright (c) 2021 American Academic Scientific Research Journal for Engineering, Technology, and Sciences
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
Authors who submit papers with this journal agree to the following terms:
- Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
- Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
- Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access).
- By submitting the processing fee, it is understood that the author has agreed to our terms and conditions which may change from time to time without any notice.
- It should be clear for authors that the Editor In Chief is responsible for the final decision about the submitted papers; have the right to accept\reject any paper. The Editor In Chief will choose any option from the following to review the submitted papers:A. send the paper to two reviewers, if the results were negative by one reviewer and positive by the other one; then the editor may send the paper for third reviewer or he take immediately the final decision by accepting\rejecting the paper. The Editor In Chief will ask the selected reviewers to present the results within 7 working days, if they were unable to complete the review within the agreed period then the editor have the right to resend the papers for new reviewers using the same procedure. If the Editor In Chief was not able to find suitable reviewers for certain papers then he have the right to accept\reject the paper.B. sends the paper to a selected editorial board member(s). C. the Editor In Chief himself evaluates the paper.
- Author will take the responsibility what so ever if any copyright infringement or any other violation of any law is done by publishing the research work by the author
- Before publishing, author must check whether this journal is accepted by his employer, or any authority he intends to submit his research work. we will not be responsible in this matter.
- If at any time, due to any legal reason, if the journal stops accepting manuscripts or could not publish already accepted manuscripts, we will have the right to cancel all or any one of the manuscripts without any compensation or returning back any kind of processing cost.
- The cost covered in the publication fees is only for online publication of a single manuscript.